1 June 2024 true No description of principal activity Taxfiler 2024.6 14103349 business:PrivateLimitedCompanyLtd 2024-06-01 2025-05-31 14103349 2024-05-31 14103349 business:EntityHasNeverTraded 2024-06-01 2025-05-31 14103349 2024-06-01 2025-05-31 14103349 business:AuditExempt-NoAccountantsReport 2024-06-01 2025-05-31 14103349 business:FilletedAccounts 2024-06-01 2025-05-31 14103349 2025-05-31 14103349 business:Director1 2024-06-01 2025-05-31 14103349 business:RegisteredOffice 2024-06-01 2025-05-31 14103349 2024-05-31 14103349 core:ShareCapital core:PreviouslyStatedAmount 2025-05-31 14103349 core:ShareCapital core:PreviouslyStatedAmount 2024-05-31 14103349 core:PreviouslyStatedAmount 2025-05-31 14103349 core:PreviouslyStatedAmount 2024-05-31 14103349 business:SmallEntities 2024-06-01 2025-05-31 14103349 countries:EnglandWales 2024-06-01 2025-05-31 14103349 2023-06-01 2024-05-31 iso4217:GBP xbrli:pure
Company Registration No. 14103349 (England and Wales)
Citi Healthcare Ltd Unaudited accounts for the year ended 31 May 2025
Citi Healthcare Ltd Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Citi Healthcare Ltd Company Information for the year ended 31 May 2025
Director
Khalil AYOMIDE
Company Number
14103349 (England and Wales)
Registered Office
99 The Avenue Bentley Doncaster DN5 0PS England
- 3 -
Citi Healthcare Ltd Statement of financial position as at 31 May 2025
2025
2024
Notes
£
£
Current assets
Cash at bank and in hand
10
10
Net current assets
10
10
Net assets
10
10
Capital and reserves
Called up share capital
10
10
Shareholders' funds
10
10
For the year ending 31 May 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 19 February 2026 and were signed on its behalf by
Khalil AYOMIDE Director Company Registration No. 14103349
- 4 -
Citi Healthcare Ltd Notes to the Accounts for the year ended 31 May 2025
1
Statutory information
Citi Healthcare Ltd is a private company, limited by shares, registered in England and Wales, registration number 14103349. The registered office is 99 The Avenue, Bentley, Doncaster, DN5 0PS, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Average number of employees
During the year the average number of employees was 0 (2024: 0).
- 5 -